Home › Articles › Volume 11, Issue 2 › Evaluating the Effects of Topical Timolol 0.5% (Opht...
Moradabad, India
Original Article
Dermatology

Evaluating the Effects of Topical Timolol 0.5% (Ophthalmic Solution) Over the Scalp in Case of Infantile Hemangioma


Volume 11, Issue 2, Pages 13-16

Authors

Affiliation:
1Assistant Professor, Department of Dermatology, Varun Arjun Medical College and Rohilkhand Hospital, Banthra, , Shahjahanpur, Uttar Pradesh, India,
2Assistant Professor, Department of Dermatology, Netaji Subhas Medical College and Hospital, Bihta, Patna, Bihar, India.

Corresponding Author

Niraj

Abstract

Background: Infantile hemangioma (IH) is the most common tumour reported during infancy. These lesions are mostly proliferate during the first year of life after that involutions naturally happen within 7 years of age. We studied 15 patients out of whom seven completed all follow ups who were treated for IH on the scalp with topical application of 0.5% timolol maleate ophthalmic solution. The aims & objectives is to evaluate the effects and adverse effects of 0.5% topical timolol maleate solution in infantile hemangioma on the scalp. Subjects and Methods: Up to six month old children were included and treated with the drops of 0.5% timolol maleate ophthalmic solution twice daily on the lesions for 6 months. At the end of the study, patients were assessed about the acceptable outcome like, cosmetically acceptance, functional improvement, adverse reactions, especially alopecia. Results: Out of fifteen, seven children treated and followed up with timolol topical application. After six months treatment with 0.5% timolol maleate ophthalmic solution, the ratio of lesions which had complete improvement was 28.57% (2/7), substantial change in 14.28% (1/7), moderate change in 14.28% (1/7), fair change in 14.28% (1/7), minimal change in 14.28% (1/7), and only 1/7 cases (14.28%) did not change and the lesion increased in size. There were no adverse effects observed. Conclusion: Timolol maleate 0.5% ophthalmic solution has showed promising and safe results for the treatment of infantile hemangioma of scalp after 6 months of treatment without any significant side effect.

Keywords

Infantile Hemangioma, Timolol, Infantile Scalp Tumor.

History

Received 05 November 2021

Revised 24 December 2021

Accepted 06 January 2022

DOI

10.47009/ajmr.2022.11.2.3

Author Notes

Corresponding Author: Niraj, Assistant Professor, Department of Dermatology, Varun Arjun Medical College and Rohilkhand Hospital, Banthra,, Shahjahanpur, Uttar Pradesh, India. E-mail:

Open Access

It is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits authors to retain ownership of the copyright for their content, and allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. https://creativecommons.org/licenses/by/4.0/

Copyright

Copyright: © the author(s), 2022.

Cite this Article

Formats

                                                
Actions
Download PDF
Metrics
10
Downloads
8
Views
Journal
Journal Asian Journal of Medical Research
Volume Volume 11
Issue Issue 2
Year 2022

Purchase access plans

Select the plan that best fits your need

Loading plans...

Statistics:

Views: 0
Downloads: 0

Asian Journal of Medical Research (AJMR) is an international, peer-reviewed, quarterly open-access journal publishing advanced research across medical specialties.

Quick Links

For Authors

© 2026 Asian Journal of Medical Research. All Rights Reserved.Designed and Developed By Kryoni